Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PGWD: Integrating Personal Genome for Warfarin Dosing.

Interdisciplinary sciences, computational life sciences - 1 Mar 2016

Pan Yidan, Cheng Ronghai, Li Zhoufang, Zhao Yujun, He Jiankui

Abstract excerpt

Warfarin is a drug normally used in the prevention of thrombosis and the formation of blood clots. The dosage of warfarin is strongly affected by genetic variants of CYP2C9 and VKORC1 genes. Current technologies for detecting the variants of these genes are mainly based on real-time PCR. In recent years, due to the rapidly dropping cost of whole genome sequencing and genotyping, more and more people get their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Algorithms
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Pharmacogenetics

Share to Software

Share to User-Computer Interface

Share to Warfarin

Source

Identifiers

PMID: 26267707
DOI: 10.1007/s12539-015-0277-6

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PGWD: Integrating Personal Genome for Warfarin Dosing.PMID 26267707Read ↗

Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).Semantic proximity Read ↗

Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.Semantic proximity Read ↗

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.Semantic proximity Read ↗

Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.Semantic proximity Read ↗

Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.Semantic proximity Read ↗

Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolism.Semantic proximity Read ↗

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.Semantic proximity Read ↗

Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.Semantic proximity Read ↗

Integration of genetic, clinical, and INR data to refine warfarin dosing.Semantic proximity Read ↗

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.Semantic proximity Read ↗

Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population.Semantic proximity Read ↗

Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.